Bristol Myers Squibb says it will buy drug developer RayzeBio for about $4.1 billion.
Share:
More In Business
Presidential Betting Brought in Billions During the 2024 Election... Is This the New Norm?
Charles Gillespie, Founder and CEO of Gambling.com Group comments on the billions of dollars in wagers placed on the outcome of the 2024 election and more.
Big Business This Week: Trump Change, Splitting Google, Spirited Away
A look ahead at who's going to be running the economy next year. Plus, the future of Chrome, the bankruptcy of Spirit, and a whole lotta Elon.
Danny Trejo is Unearthing Mysteries with the History Channel
Danny Trejo joined Cheddar to discuss his upcoming show "Mysteries Unearthed" coming to the History Channel and his most recent entrepreneurial ventures.
Dreaming of Being Part of The Royal Family? Now You can with Royaland
His Royal Highness Prince Emanuele Filiberto Di Savoia, Prince of Venice, joined Cheddar to discuss his new game that lets everyday folks feel like a royal.
Why Communications Data is the New Oil
Tom Padgett, President of Smarsh, discusses how Smarsh unlocks the value of compliance. Sponsored by Smarsh.
Red Robin CEO Calls Shake Shack's Partnership with Delta 'Challenging Risk'
GJ Hart, CEO of Red Robin, discusses the company's place in the "value wars," what's next for the restaurant and his thoughts on Shake Shack in the sky. Watch!
Megatrends: Trends Businesses Need to Lookout for in 2025
Chiza Vitta, Managing Director Global Analytics at S&P Global Ratings joined Cheddar to discuss S&P's recent Megatrend findings and other 2025 predictions.
Is Wellness Tourism the Next Big Reason to Travel?
Greg O'Hara CEO at Certares joined Cheddar to discuss his personal experience with Wellness Tourism and his predictions for the future of the growing industry.
Are Trump's Cabinet Picks Moving the Markets?
Jacob Sonenshine, stock pick writer at Barron's, joins Cheddar to discuss how Trump's win (and cabinet picks) are affecting the stock market. Watch!
